Abstract
A ≥40% relative decline in estimated glomerular filtration rate (eGFR) has been supported for use as a surrogate endpoint for clinical outcomes. However, the associations between this change and resulting days that a patient spends out of their primary ambulatory residence (e.g., during inpatient admissions and nursing facility stays) and cost outcomes are limited. The purpose of this analysis was to evaluate the associations of relative changes in eGFR with days out of the home and with cost outcomes in patients with type 2 diabetes mellitus (T2DM).
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have